Neurocognitive effects of aripiprazole versus olanzapine in patients with stable psychosis

被引：0
|
作者：
Cornblatt, BA
Kern, RS
Carson, WH
Ali, MW
Green, MF
机构：
[1] Hillside Hosp, Glen Oaks, NY 11004 USA
[2] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[4] Otsuka Maryland Res Inst LLC, Rockville, MD USA
来源：
BIOLOGICAL PSYCHIATRY | 2002年 / 51卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
482
引用
收藏
页码：165S / 165S
页数：1
相关论文
共 50 条
  • [21] Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis
    Block, Jerald J.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (10): : 1838 - 1838
  • [22] Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo
    L'ltalien, Gilbert J.
    Casey, Daniel E.
    Kan, Hong J.
    Carson, William H.
    Marcus, Ronald N.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (10) : 1510 - 1516
  • [23] Dissociating medication effects from learning and practice effects in a neurocognitive study of schizophrenia: Olanzapine versus haloperidol
    Boulay, LJ
    Labelle, A
    Bourget, D
    Robertson, S
    Tessier, P
    Habib, R
    Tombaugh, T
    Milin, R
    Ward, H
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 204 - 204
  • [24] Olanzapine treatment of parkinsonian patients with psychosis
    Stover, NP
    Juncos, JL
    [J]. NEUROLOGY, 1999, 52 (06) : A215 - A215
  • [25] Benefits of switching schizophrenic patients from olanzapine to aripiprazole
    Moriwaki, M.
    Furukawa, O.
    Fujita, K.
    Iwata, N.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 126 - 126
  • [26] Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis
    Keefe, RSE
    Seidman, LJ
    Christensen, BK
    Hamer, RM
    Sharma, T
    Sitskoorn, MM
    Rock, SL
    Woolson, S
    Tohen, M
    Tollefson, GD
    Sanger, TM
    Lieberman, JA
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (02) : 97 - 105
  • [27] Combination of aripiprazole and olanzapine in first episode psychosis patient with metabolic syndrome: A case report
    Licanin, I.
    Senad, H.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S755 - S756
  • [28] Effects of Aripiprazole, Risperidone, and Olanzapine on 5-HT1A Receptors in Patients With Schizophrenia
    Lerond, Jerome
    Lothe, Amelie
    Ryvlin, Philippe
    Bouvard, Sandrine
    d'Amato, Thierry
    Ciumas, Carolina
    Dalery, Jean
    Poulet, Emmanuel
    Saoud, Mohamed
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 84 - 89
  • [29] Effects of aripiprazole and olanzapine on serum triglyceride: High density lipoprotein ratios in patients with schizophrenia
    Meyer, J. M.
    Baker, R. A.
    Crandall, D.
    Pultz, J.
    Pikalov, A.
    McQuade, R.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 447 - 447
  • [30] Comparison of impaired glucose tolerance in mice treated with olanzapine versus aripiprazole
    Shimada, Masahiko
    Ohsawa, Masahiro
    Miyata, Shigeo
    Hayashi, Shun-suke
    Yoshikawa, Naoki
    Carlsson, Anna
    Kamei, Junzo
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 229P - 229P
12345